Latest Sirolimus Stories
Rapamycin, a drug that keeps the immune system from attacking transplanted organs, may have another exciting use: fighting Alzheimer's disease.
JAMAICA PLAIN, Mass., Feb. 4 /PRNewswire/ -- Paloma Pharmaceuticals, Inc. announced today that it has received acceptance of its IND to enter Phase I studies with Palomid 529 (P529) in patients with age-related macular degeneration (AMD).
Research performed at UC Santa Barbara points to the drug rapamycin as a potential treatment for kidney disease.
Tuberous sclerosis, commonly associated with autism, is linked to defects in axon guidance.
LA JOLLA, Calif., Jan. 5 /PRNewswire/ -- Intellikine, Inc.
After suffering heart attacks, patients often receive stents designed to hold their arteries open.
A drug that has become a mainstay of multiple myeloma treatment may outperform alternative therapies in re-establishing the immune system of patients who have received stem cell transplants from unrelated, partially matched donors.
FORT LAUDERDALE, Fla., Dec.
JAMAICA PLAIN, Mass., Nov. 16 /PRNewswire/ -- Paloma Pharmaceuticals, Inc.
Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
- An armed gangster.